دانلود کتاب راهنمای کامل APRN و PA برای تجویز دارو درمانی

The APRN and PA’s Complete Guide to Prescribing Drug Therapy 2022 is a prescribing reference intended for use by healthcare providers in all clinical practice settings who are involved in the primary care management of patients with acute, episodic, and chronic health problems and needs for health promotion and disease prevention. It is organized in a concise and easy-to-read format. Comments are interspersed throughout, including such clinically useful information as laboratory values to be monitored, patient teaching points, and safety information. If pediatric indications for a drug have not been established or a drug is not recommended for a pediatric subgroup, this information is noted accordingly. This reference is divided into two major sections. Section I presents drug treatment regimens for over 600 clinical diagnoses. Each drug is listed alphabetically by generic name, followed by: FDA pregnancy category (A, B, C, D, X); over-the-counter availability (OTC); DEA schedule (I, II, III, IV, V); generic availability (G); dosing regimens; brand/trade name(s); dose forms; whether tablets, caplets, or chew tabs are single scored (*), cross-scored (**), or tri-scored (***); flavors of chewable, sublingual, buccal, and liquid forms; and information regarding additives (i.e., dye-free, sugar-free, preservative-free or preservative type, alcoholfree or alcohol content). Non-pharmaceutical products and drugs that received initial FDA approval on or after June 30, 2015, do not have an FDA pregnancy letter designation. For information regarding special populations, including pregnant and breastfeeding females, refer to the manufacturer’s package insert or visit https://www.accessdata.fda.gov/scripts/cder/daf/ to view the product label online. Visit https://www.drugs.com/pregnancy-categories.html to view the FDA Pregnancy and Lactation Labeling Final Rule (PLLR) and new label format. Section II presents clinically useful information organized in table format, including: the JNC-8 and ASH recommendations for hypertension management, childhood immunization recommendations, brand/trade name drugs (with contents) for the management of common respiratory symptoms, anti-infectives by classification, pediatric dosing by weight for liquid forms, glucocorticosteroids by potency and route of administration, and contraceptives by route of administration and estrogen and/or progesterone content. An alphabetical cross-reference index of drugs by generic and brand/trade name, with FDA pregnancy category and controlled drug schedule, facilitates quick identification of drugs by alternate names and page location(s).